EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression

Christophe Quemerais, Christine Jean, Alexia Brunel, Emilie Decaup, Guillaume Labrousse, Hippolyte Audureau, Jérôme Raffenne, Ismahane Belhabib, Jérôme Cros, Aurélie Perraud, Nelson Dusetti, Remy Nicolle und 5 weitere

Cancer Letters · 2025-04 · 614 · 217538

DOI: 10.1016/j.canlet.2025.217538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025-04. Verfasst von Christophe Quemerais und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center of Toulouse (CRCT), INSERM UMR-1037, CNRS UMR-5071, Team « Labellisée Ligue Contre le Cancer EL2021», University of Toulouse, …. Hauptthemen laut MEDLINE: Pancreatic Stellate Cells, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Tacrolimus Binding Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National League Against Cancer, French National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In pancreatic ductal adenocarcinoma (PDAC), fibroblast activation leads to excessive secretion of extracellular matrix (ECM) and soluble factors that regulate tumor progression, prompting investigation into endoplasmic reticulum (ER)-resident proteins that may support this activation. We identified FKBP7, a peptidyl-prolyl isomerase in the ER, as overexpressed in PDAC stroma compared to cancer cells, and in patients with favorable prognosis. Analysis of single-cell RNA sequencing databases revealed FKBP7 expression in pancreatic stellate cells (PSCs) and cancer-associated fibroblasts (CAFs). When analyzed by immunohistochemistry on PDAC patient tissues, FKBP7 emerged as an early activation marker in the preneoplastic stroma, preceding αSMA expression, and responding to FAK- and TGFβ-induced stiffening and pro-fibrotic programs in PSCs. Functional analyses revealed that FKBP7 knockdown in PSCs enhanced contractility, Rho/FAK signaling, and secretion of pro-inflammatory cytokines as well as remodeling of type I collagen, promoting an activated phenotype and accelerating tumor growth in vivo. Conversely, FKBP7 expression supported a tumor-restraining (i.e. encapsulating) ECM characterized by type IV collagen. Mechanistically, FKBP7 interacts with BiP, and blocking this interaction instead leads to increased PSC secretion of type I collagen. Thus, FKBP7 serves as a novel PSC marker and ER regulator in a complex with BiP of the secretion of specific collagen subtypes, highlighting its potential to mediate ECM normalization and constrain PDAC tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Stellate CellsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalTacrolimus Binding ProteinsEndoplasmic ReticulumCollagenHumansAnimalsDisease ProgressionMiceCell Line, TumorCancer-Associated FibroblastsSignal TransductionExtracellular MatrixGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BiPCancer-associated fibroblastsCollagenEndoplasmic reticulumExtracellular matrixPancreatic cancerPancreatic stellate cells

Substanzen

Tacrolimus Binding ProteinsCollagen

Autor:innen und Institutionen

  • Cancer Research Center of Toulouse (CRCT), INSERM UMR-1037, CNRS UMR-5071, Team « Labellisée Ligue Contre le Cancer EL2021», University of Toulouse, France.
  • Department of Pathology, Beaujon-Bichat University Hospital - Paris Diderot University, Clichy, France.
  • EA 3842 Laboratory, Medicine and Pharmacy Faculties, University of Limoges, France.
  • Cancer Research Center of Marseille (CRCM), INSERM UMR-1068, CNRS UMR-7258, Marseille, France.
  • Center of Research on Inflammation (CRI), INSERM U1149, Paris, France.
  • Cancer Research Center of Toulouse (CRCT), INSERM UMR-1037, CNRS UMR-5071, Team « Labellisée Ligue Contre le Cancer EL2021», University of Toulouse, France. Electronic address: corinne.bousquet@inserm.fr.

Förderung

  • National League Against Cancer
  • French National Cancer Institute

Zitieren

APA

Quemerais, C., Jean, C., Brunel, A., Decaup, E., Labrousse, G., Audureau, H., Raffenne, J., Belhabib, I., Cros, J., Perraud, A., Dusetti, N., Nicolle, R., Mathonnet, M., Pyronnet, S., Martineau, Y., Fanjul, M., & Bousquet, C. (2025). Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression. Cancer Letters, 614, 217538. https://doi.org/10.1016/j.canlet.2025.217538

Vancouver

Quemerais C, Jean C, Brunel A, Decaup E, Labrousse G, Audureau H, et al. Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression. Cancer Letters. 2025;614:217538. doi:10.1016/j.canlet.2025.217538

BibTeX
@article{Quemerais2025,
  author = {Quemerais, Christophe and Jean, Christine and Brunel, Alexia and Decaup, Emilie and Labrousse, Guillaume and Audureau, Hippolyte and Raffenne, Jérôme and Belhabib, Ismahane and Cros, Jérôme and Perraud, Aurélie and Dusetti, Nelson and Nicolle, Remy and Mathonnet, Muriel and Pyronnet, Stéphane and Martineau, Yvan and Fanjul, Marjorie and Bousquet, Corinne},
  title = {Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression},
  journal = {Cancer Letters},
  year = {2025},
  volume = {614},
  pages = {217538},
  doi = {10.1016/j.canlet.2025.217538}
}
Kostenlos starten →